简体中文 | 繁體中文 | English

Press Releases

2024-09-23 10:20 Neu-REFIX Beta glucan receives rare pediatric disease and orphan drug designations from the US FDA for treatment of Duchenne Muscular Dystrophy
2024-09-20 18:23 New Arthur D. Little/POLIS Future of Mobility Report Outlines Potential Solutions to Double Global Sustainable Mobility
2024-09-20 18:20 GC Aesthetics® Launches YOUTHLY™: A New Era for Breast Implants in China
2024-09-20 18:15 Neuraptive Therapeutics Announces Presentation of Phase 2 Topline Interim Results for NTX-001 at the 2024 American Society for Surgery of the Hand (ASSH) Annual Meeting
2024-09-20 18:11 Mary Kay Expands Into Kyrgyzstan, Further Elevating Beauty and Empowerment Around the World
2024-09-20 18:03 LIBER HOTEL OSAKA Introducing the "MUJI room" for an Immersive MUJI Experience
2024-09-20 17:59 Dubai Future Foundation Issues Special ‘Global 50’ Report on Youth Ahead of UN Summit
2024-09-20 17:55 Uniphore Unveils X-Stream to Revolutionize Enterprise Digital Transformation with Knowledge-as-a-Service
2024-09-20 17:53 NetApp Signs Strategic Collaboration Agreement with AWS to Enhance Cloud-Based Data Services
2024-09-20 17:46 SLB and NVIDIA collaborate to develop generative AI solutions for the energy sector
2024-09-20 17:44 Experian Ranked 7th on 2024 IDC FinTech Rankings Top 100; Wins IDC Real Results Award in Bank Deposit Transformation
2024-09-20 08:03 NIKE, Inc. Board of Directors Announces Long-Time Nike Veteran Elliott Hill to Return as President and Chief Executive Officer John Donahoe to Retire from Nike
2024-09-20 08:01 Sandvine: Our Next Chapter as a Market Leader for Technology Solutions
2024-09-20 07:57 Sandvine Announces New Ownership and Capital Infusion
2024-09-20 07:51 MSCI Sets the Bar for Assessing Carbon Project Integrity With Launch of New Ratings
2024-09-20 07:46 Savour Global Flavours: Hong Kong Wine & Dine Festival Returns for a 5-Day Culinary Celebration
2024-09-20 07:44 Dfns Wallet Infrastructure Now Available on Temenos Exchange
2024-09-20 07:39 Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
2024-09-20 07:35 Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries
2024-09-19 20:22 Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024

Business Wire Weibo

Industries

Latest Releases